|
Ding WY, Proietti M, Boriani G, Fauchier L, Blomstrom-Lundqvist C, Marin F, Potpara TS, Lip GYH; ESC-EHRA EORP-AF Long-Term General Registry Investigators. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry. Europace. 2022 May 3;24(5):721-728. doi: 10.1093/europace/euab280. PubMed PMID: 35446354.
AÑO: 2022; IF: 6.1
|
35446354
|
Rivera-Caravaca JM, Lip GYH, Roldan V, Marin F. Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system. Front Cardiovasc Med. 2022 Oct 17;9:1042728. doi: 10.3389/fcvm.2022.1042728. eCollection 2022. No abstract available. PubMed PMID: 36324744; PubMed Central PMCID: PMC9619039.
AÑO: 2022; IF: 3.6
|
|
Sanmartin Fernandez M, Anguita Sanchez M, Arribas F, Baron-Esquivias G, Barrios V, Cosin-Sales J, Esteve-Pastor MA, Freixa-Pamias R, Lekuona I, Perez-Cabeza AI, Urena I, Vazquez Rodriguez JM, Rafols Priu C, Marin F. Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study. Cardiol J. 2022;29(4):601-609. doi: 10.5603/CJ.a2022.0044. Epub 2022 May 27. PubMed PMID: 35621092; PubMed Central PMCID: PMC9273239.
AÑO: 2022; IF: 2.9
|
|
Rivera-Caravaca JM, Ding WY, Marin F, Roldan V, Lip GYH; Christina J.-Y. Lee MD, PhD; Christian Torp-Pedersen MD, DMSc. Prediction of ischemic stroke in different populations: a comparison of absolute stroke risk and CHA2DS2-VASc in real-world and clinical trial patients. Eur J Intern Med. 2022 Apr;98:122-124. doi: 10.1016/j.ejim.2021.12.014. Epub 2021 Dec 21. No abstract available. PubMed PMID: 34952769.
AÑO: 2022; IF: 8.0
|
|
Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Sanmartin Fernandez M, Arribas F, Masjuan J, Barrios V, Cosin-Sales J, Freixa-Pamias R, Recalde E, Perez-Cabeza AI, Manuel Vazquez Rodriguez J, Rafols Priu C, Anguita Sanchez M, Lip GYH, Marin F. Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 15;9(1):38-46. doi: 10.1093/ehjcvp/pvac060. PubMed PMID: 36318457.
AÑO: 2022; IF: 7.1
|